Compugen Ltd (NASDAQ:CGEN)

Data as of Jan 28
 -0.24 / -2.94%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Tel Aviv, Israel.

Contact Information

Compugen Ltd.
72 Pinchas Rosen Street
Tel Aviv -- 69512
P:(723) 765-8585
Investor Relations:



Mutual fund holders4.84%
Other institutional3.22%
Individual stakeholders--

Top Executives

Anat Cohen-DayagPresident & Chief Executive Officer
Ari KrashinChief Financial Officer
Zurit LevineVice President-Research & Discovery
Tsipi Keren-LehrerVice President-Business Development
Eyal NeriaVice President-Development

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.